ZTSZoetis Inc.

NYSE zoetis.com


$ 170.67 $ 2.05 (1.22 %)    

Thursday, 28-Mar-2024 14:14:50 EDT
QQQ $ 444.36 $ -0.34 (-0.08 %)
DIA $ 397.90 $ -0.28 (-0.07 %)
SPY $ 523.56 $ 0.35 (0.07 %)
TLT $ 94.63 $ 0.17 (0.18 %)
GLD $ 205.62 $ 0.67 (0.33 %)
$ 168.51
$ 168.62
$ 170.62 x 100
$ 0.00 x 0
$ 167.55 - $ 171.14
$ 150.69 - $ 201.46
2,857,848
na
77.9B
$ 0.98
$ 33.23
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-13-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-14-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-15-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 02-16-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 02-13-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-06-2019 08-06-2019 10-Q
20 05-02-2019 03-31-2019 10-Q
21 02-14-2019 12-31-2018 10-K
22 11-01-2018 09-30-2018 10-Q
23 08-02-2018 06-30-2018 10-Q
24 05-02-2018 03-31-2018 10-Q
25 02-15-2018 12-31-2017 10-K
26 11-02-2017 10-01-2017 10-Q
27 08-08-2017 07-02-2017 10-Q
28 05-04-2017 04-02-2017 10-Q
29 02-16-2017 12-31-2016 10-K
30 11-03-2016 10-02-2016 10-Q
31 08-05-2016 07-03-2016 10-Q
32 05-06-2016 04-03-2016 10-Q
33 02-24-2016 12-31-2015 10-K
34 11-05-2015 09-27-2015 10-Q
35 08-06-2015 06-28-2015 10-Q
36 05-07-2015 03-29-2015 10-Q
37 02-27-2015 12-31-2014 10-K
38 11-10-2014 09-28-2014 10-Q
39 08-12-2014 06-29-2014 10-Q
40 05-13-2014 03-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 largest-animal-health-firm-zoetis-hit-with-european-probe-over-possible-breach-of-competition-rules-related-to-dog-pain-medicine

The European Commission launches probe into Zoetis over alleged market interference in dog pain medication launch. Focus on Zoe...

 markets-tumble-vix-up-8-on-hot-inflation-data-dollar-yields-jump-as-traders-unwind-rate-cut-bets-whats-driving-markets-tuesday

Wall Street witnessed one of the worst sessions since the beginning of the year, with widespread declines across the board as s...

 animal-health-focused-zoetis-stock-faces-near-term-pressure-analyst-cites-uncertainty-in-q4-results-weak-margins

Zoetis' Q4 2023 performance with $2.21 billion revenue, 8% YoY growth, and strong sales in companion animal products.

 zoetis-q4-adjusted-eps-124-misses-132-estimate-sales-221b-beat-219b-estimate

Zoetis (NYSE:ZTS) reported quarterly earnings of $1.24 per share which missed the analyst consensus estimate of $1.32 by 6.06 p...

 earnings-scheduled-for-february-13-2024

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on reven...

 goldman-sachs-maintains-buy-on-zoetis-raises-price-target-to-226

Goldman Sachs analyst Nathan Rich maintains Zoetis (NYSE:ZTS) with a Buy and raises the price target from $190 to $226.

 jefferies-assumes-zoetis-at-buy-announces-price-target-of-230

Jefferies analyst Glen Santangelo assumes Zoetis (NYSE:ZTS) with a Buy rating and announces Price Target of $230.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION